Osteoporosis, a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration, is a significant public health concern. With the aging population, the prevalence of osteoporosis is expected to increase. This article provides an overview of the advancements in the management of osteoporosis, focusing on recent therapeutic options and diagnostic tools.
New imaging techniques have revolutionized the diagnosis of osteoporosis. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides detailed images of the bone microarchitecture, enhancing the prediction of fracture risk. Trabecular bone score (TBS), a texture parameter that evaluates pixel grey-level variations in lumbar spine dual-energy X-ray absorptiometry (DXA) images, is another promising tool that provides additional information about bone quality.
Recent years have witnessed the emergence of novel pharmacological treatments. Anti-sclerostin antibodies, such as romosozumab, increase bone formation and decrease bone resorption, showing a significant reduction in vertebral and non-vertebral fractures. Anabolic agents like Teriparatide and Abaloparatide stimulate bone formation, offering another therapeutic avenue. Moreover, Denosumab, a RANKL inhibitor, has demonstrated superior efficacy in increasing bone mineral density (BMD) and reducing fracture risk.
Non-pharmacological interventions remain integral to osteoporosis management. These include lifestyle modifications such as adequate calcium and vitamin D intake, regular weight-bearing exercise, smoking cessation, and limiting alcohol intake. Furthermore, fall prevention strategies are vital in reducing fracture risk in this population.
The landscape of osteoporosis management is rapidly evolving, with advancements in both diagnostic tools and therapeutic options. These innovations promise a more comprehensive and personalized approach to osteoporosis care. Healthcare professionals need to stay updated with these advancements to optimize patient outcomes and reduce the burden of this debilitating disease.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation